Claudia Abrantes Mimoso, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
RNA Polymerase II | 5 | 2023 | 551 | 1.820 |
Why?
|
Ribonucleoprotein, U1 Small Nuclear | 1 | 2023 | 36 | 0.910 |
Why?
|
Nucleotides | 1 | 2023 | 462 | 0.770 |
Why?
|
Epidermis | 1 | 2014 | 523 | 0.380 |
Why?
|
RNA Splicing | 2 | 2023 | 904 | 0.300 |
Why?
|
Spliceosomes | 2 | 2023 | 111 | 0.260 |
Why?
|
RNA Splice Sites | 2 | 2023 | 209 | 0.250 |
Why?
|
Introns | 2 | 2023 | 995 | 0.220 |
Why?
|
Biotin | 1 | 2023 | 253 | 0.220 |
Why?
|
RNA Precursors | 1 | 2023 | 207 | 0.210 |
Why?
|
Polyadenylation | 1 | 2022 | 116 | 0.200 |
Why?
|
beta-Globins | 1 | 2021 | 113 | 0.180 |
Why?
|
Endonucleases | 1 | 2022 | 383 | 0.180 |
Why?
|
RNA, Messenger | 3 | 2023 | 13013 | 0.180 |
Why?
|
Erythroid Cells | 1 | 2021 | 238 | 0.170 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9423 | 0.150 |
Why?
|
Mammals | 1 | 2023 | 1113 | 0.150 |
Why?
|
Erythropoiesis | 1 | 2021 | 703 | 0.140 |
Why?
|
RNA | 2 | 2023 | 2725 | 0.140 |
Why?
|
Transcription, Genetic | 3 | 2023 | 7718 | 0.120 |
Why?
|
DNA Helicases | 1 | 2019 | 851 | 0.110 |
Why?
|
Chromatin | 2 | 2023 | 2847 | 0.100 |
Why?
|
Molecular Sequence Annotation | 1 | 2014 | 525 | 0.100 |
Why?
|
Keratinocytes | 1 | 2014 | 794 | 0.090 |
Why?
|
DNA Repair | 1 | 2019 | 2037 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1850 | 0.090 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5856 | 0.080 |
Why?
|
Interleukin-17 | 1 | 2014 | 897 | 0.080 |
Why?
|
Cell Separation | 1 | 2014 | 1739 | 0.080 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5869 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2014 | 2721 | 0.070 |
Why?
|
Psoriasis | 1 | 2014 | 888 | 0.070 |
Why?
|
Animals | 5 | 2023 | 168756 | 0.060 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.060 |
Why?
|
DNA | 1 | 2019 | 7281 | 0.060 |
Why?
|
Monocytes | 1 | 2014 | 2588 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12139 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2022 | 430 | 0.050 |
Why?
|
Nucleosomes | 1 | 2023 | 487 | 0.050 |
Why?
|
Cytokines | 1 | 2014 | 7303 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2023 | 617 | 0.040 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2019 | 68 | 0.040 |
Why?
|
beta-Thalassemia | 1 | 2021 | 224 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2022 | 3651 | 0.040 |
Why?
|
Xenopus | 1 | 2019 | 711 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2019 | 752 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2438 | 0.030 |
Why?
|
Ubiquitination | 1 | 2019 | 1003 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 849 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16684 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 13893 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2014 | 665 | 0.030 |
Why?
|
Leukocytes | 1 | 2021 | 2044 | 0.030 |
Why?
|
DNA Replication | 1 | 2019 | 1389 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2014 | 669 | 0.020 |
Why?
|
Binding Sites | 1 | 2019 | 6114 | 0.020 |
Why?
|
Base Sequence | 1 | 2021 | 12816 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2014 | 2269 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4815 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9378 | 0.020 |
Why?
|
Mice | 2 | 2023 | 81104 | 0.020 |
Why?
|
Humans | 6 | 2023 | 740505 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2021 | 11475 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10953 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9639 | 0.010 |
Why?
|
Female | 2 | 2019 | 379368 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19262 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9279 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 29819 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23397 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 62758 | 0.000 |
Why?
|